Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid

Biological Chemistry

Volumn 390, Issue 4, 2009, Pages 313-317

  Zöllner, Andy ^a   Dragan, Calin Aurel ^a   Pistorius, Dominik ^b   Müller, Rolf ^b   Bode, Helge B ^b   Peters, Frank T ^c   Maurer, Hans H ^c   Bureik, Matthias ^a  

^a PomBioTech GmbH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Breast cancer; Cancer treatment; Cytochrome P450; Fatty acid hydroxylation; Schizosaccharomyces pombe; Whole cell biotransformation

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 4Z1; LAURIC ACID; MYRISTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER THERAPY; HYDROXYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOSACCHAROMYCES POMBE;

CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYLATION; LAURIC ACIDS; MOLECULAR STRUCTURE; MYRISTIC ACID;

SCHIZOSACCHAROMYCES POMBE; SCHIZOSACCHAROMYCETACEAE;

EID: 64849114373     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.030     Document Type: Article

References (28)

1. Baston, E. and Leroux, F.R. (2007). Inhibitors of steroidal cytochrome p450 enzymes as targets for drug development. Recent Patents Anticancer Drug Discov. 21, 31-58.
2. Bernhardt, R. (2005). Cytochromes P-450. In: Encyclopedia of Biological Chemistry, Vol. 1, 1st edition, W. Lennarz, M. Lane, P. Modrich, J. Dixon, E. Carafoli, J. Exton and D. Cleveland, eds. (New York, USA: Academic Press), pp. 544-549.
3. Bligh, E.G. and Dyer, W.J. (1959). A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 378, 911-917.
4. Bode, H.B., Ring, M.W., Schwar, G., Kroppenstedt, R.M., Kaiser, D., and Muller, R. (2006). 3-Hydroxy-3-methylglutaryl-coenzyme A (CoA) synthase is involved in biosynthesis of isovaleryl-CoA in the myxobacterium Myxococcus xanthus during fruiting body formation. J. Bacteriol. 188, 6524-6528.
5. Cabello-Hurtado, F., Batard, Y., Salaun, J.P., Durst, F., Pinot, F., and Werck-Reichhart, D. (1998). Cloning, expression in yeast, and functional characterization of CYP81B1, a plant cytochrome P450 that catalyzes in-chain hydroxylation of fatty acids. J. Biol. Chem. 27313, 7260-7267.
6. Chajes, V., Niyongabo, T., Lanson, M., Fignon, A., Couet, C., and Bougnoux, P. (1992). Fatty-acid composition of breast and iliac adipose-tissue in breast-cancer patients. Int. J. Cancer 503, 405-408.
7. Downie, D., McFadyen, M.C.E., Rooney, P.H., Cruickshank, M.E., Parkin, D.E., Miller, I.D., Telfer, C., Melvin, W.T., and Murray, G.I. (2005). Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin. Cancer Res. 1120, 7369-7375.
8. Dragan, C.A., Zearo, S., Hannemann, F., Bernhardt, R., and Bureik, M. (2005). Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast Schizosaccharomyces pombe. FEMS Yeast Res. 56/57, 621-625.
9. 50 values of anti-prostate tumor drugs acting on CYP21. J. Enzyme Inhib. Med. Chem. 215, 547-556.
10. Eichelbaum, M. and Burk, O. (2001). CYP3A genetics in drug metabolism. Nat. Med. 73, 285-287.
11. Guengerich, F.P. (2004). Cytochrome P450: what have we learned and what are the future issues? Drug Metab. Rev. 362, 159-197.
12. Hashizume, T., Imaoka, S., Hiroi, T., Terauchi, Y., Fujii, T., Miyazaki, H., Kamataki, T., and Funae, Y. (2001). cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem. Biophys. Res. Commun. 280, 1135-1141.
13. Hietanen, E., Punnonen, K., Punnonen, R., and Auvinen, O. (1986). Fatty-acid composition of phospholipids and neutral lipids and lipid-peroxidation in human-breast cancer and lipoma tissue. Carcinogenesis 712, 1965-1969.
14. Hsu, M.H., Savas, U., Griffin, K.J., and Johnson, E.F. (2007). Human cytochrome P450 family 4 enzymes: function, genetic variation and regulation. Drug Metab. Rev. 392-393, 515-538.
15. Maundrell, K. (1990). nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J. Biol. Chem. 265, 10857-10864.
16. Maundrell, K. (1993). Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene 1231, 127-130.
17. Nebert, D.W. and Nelson, D.R. (1991). P450 gene nomenclature based on evolution. Methods Enzymol. 206, 3-11.
18. Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M., and Nebert, D.W. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 141, 1-18.
19. Okita, R.T. and Okita, J.R. (2001). Cytochrome P450 4A fatty acid omega hydroxylases. Curr. Drug Metab. 23, 265-281.
20. Peters, F.T., Dragan, C.A., Wilde, D.R., Meyer, M.R., Zapp, J., Bureik, M., and Maurer, H.H. (2007). Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4′-hydroxymethyl-a- pyrrolidinobutyrophenone. Biochem. Pharmacol. 743, 511-520.
21. Rettie, A.E. and Kelly, E.J. (2008). The CYP4 family. In: Cytochromes P450: Role in the Metabolism and Toxicity of Drugs and other Xenobiotics, C. Ioannides, ed. (Cambridge, UK: RSC Publishing), pp. 385-414.
22. Rieger, M.A., Ebner, R., Bell, D.R., Kiessling, A., Rohayem, J., Schmitz, M., Temme, A., Rieber, E.P., and Weigle, B. (2004). Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res. 64, 2357-2364.
23. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd edition (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).
24. Simpson, A. (1997). The cytochrome P450 4 (CYP4) family. Gen. Pharmacol. 283, 351-359.
25. Stark, K. and Guengerich, F.P. (2007). Characterization of orphan human cytochromes P450. Drug Metab. Rev. 392-393, 627-637.
26. Stark, K., Dostalek, M., and Guengerich, F.P. (2008). Expression and purification of orphan cytochrome P450 4×1 and oxidation of anandamide. FEBS J. 275, 3706-3717.
27. Suga, M. and Hatakeyama, T. (2005). Rapid and simple procedure for high-efficiency lithium acetate transformation of cryopreserved Schizosaccharomyces pombe cells. Yeast 22, 799-804.
28. Uno, F., Sasaki, J., Nishizaki, M., Carboni, G., Xu, K., Atkinson, E.N., Kondo, M., Minna, J.D., Roth, J.A., and Ji, L. (2004). Myristoylation of the Fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res. 64, 2969-2976.